Next 10 |
2024-05-13 19:52:09 ET Start Time: 16:30 End Time: 17:11 Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Conference Call May 13, 2024, 16:30 AM ET Company Participants Tim Goodnow - President and CEO Rick Sullivan - CFO Jeff Ruiz - Head of Strategy and ...
2024-05-13 17:16:08 ET More on Senseonics Senseonics Holdings, Inc. (SENS) Q4 2023 Earnings Call Transcript Senseonics GAAP EPS of -$0.03 in-line, revenue of $5.1M beats by $0.49M Senseonics, Rimidi team up on diabetes monitoring solution Seeking Alpha’...
2024-05-13 16:07:58 ET More on Senseonics Senseonics Holdings, Inc. (SENS) Q4 2023 Earnings Call Transcript Senseonics, Rimidi team up on diabetes monitoring solution Senseonics slips amid concerns over demand for Eversense Seeking Alpha’s Quant Rating...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2024. R...
Enhancing patient care and advancing innovation with the only long-term implantable continuous glucose monitor Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitor ...
2024-05-12 17:35:55 ET Major earnings expected after the bell on Monday include: Petróleo Brasileiro S.A. - Petrobras ( PBR ) Lithium Americas (Argentina) Corp. ( LAC ) StoneCo Ltd. ( STNE ) Inovio Pharmaceuticals ( INO ) Alcon ( ALC ) ...
2024-05-09 17:06:59 ET More on Senseonics Senseonics Holdings, Inc. (SENS) Q4 2023 Earnings Call Transcript Senseonics slips amid concerns over demand for Eversense Senseonics GAAP EPS of -$0.03 beats by $0.01, revenue of $8M beats by $0.38M Seeking Alpha...
Eversense ® CGM+RPM solution to be powered by Rimidi’s clinical management platform Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) sy...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming RBC Capital Markets Globa...
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced that it plans to release its first quarter 2024 financial resu...
News, Short Squeeze, Breakout and More Instantly...
Senseonics Holdings Inc. Company Name:
SENS Stock Symbol:
NYSE Market:
Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2024. R...
Enhancing patient care and advancing innovation with the only long-term implantable continuous glucose monitor Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitor ...
Eversense ® CGM+RPM solution to be powered by Rimidi’s clinical management platform Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) sy...